A recent clinical trial demonstrated that the combination of three iron chelators, DFO, DFP, and DFX, was superior to dual therapy in lowering serum ferritin levels and also showed a positive trend in reducing myocardial iron content.
← all excerpts
Regulation of iron metabolism in ferroptosis: From mechanism research to clinical translation.
1
—
—